AIM: To compare the frequency of elevated concentrations of inflammation-related proteins in the blood of infants born before the 28th week of gestation who had documented bacteraemia and those who had presumed (antibiotic-treated but culture-negative) bacteraemia to those who had neither. METHODS: The subjects of this study are the 868 infants born at 14 institutions for whom information about protein measurements on at least two of the three protocol days (days 1, 7, and 14) was available and who did not have Bell stage 3 necrotizing enterocolitis or isolated bowel perforation, which were strongly associated with bacteraemia in this sample. RESULTS: Newborns with presumed early (week 1) bacteraemia had elevated concentrations of only a few inflammation-related proteins, while those who had presumed late (weeks 2-4) bacteraemia did not have any elevations. In contrast, newborns who had documented early bacteraemia had a moderately strong signal, while those who had documented late bacteraemia had a stronger signal with more protein concentrations elevated on two separate occasions a week apart. CONCLUSIONS: Culture-confirmed early and late bacteraemia are accompanied/followed by systemic inflammatory responses not seen with presumed early and late bacteraemia.
AIM: To compare the frequency of elevated concentrations of inflammation-related proteins in the blood of infants born before the 28th week of gestation who had documented bacteraemia and those who had presumed (antibiotic-treated but culture-negative) bacteraemia to those who had neither. METHODS: The subjects of this study are the 868 infants born at 14 institutions for whom information about protein measurements on at least two of the three protocol days (days 1, 7, and 14) was available and who did not have Bell stage 3 necrotizing enterocolitis or isolated bowel perforation, which were strongly associated with bacteraemia in this sample. RESULTS: Newborns with presumed early (week 1) bacteraemia had elevated concentrations of only a few inflammation-related proteins, while those who had presumed late (weeks 2-4) bacteraemia did not have any elevations. In contrast, newborns who had documented early bacteraemia had a moderately strong signal, while those who had documented late bacteraemia had a stronger signal with more protein concentrations elevated on two separate occasions a week apart. CONCLUSIONS: Culture-confirmed early and late bacteraemia are accompanied/followed by systemic inflammatory responses not seen with presumed early and late bacteraemia.
Authors: Thomas F McElrath; Raina Nakova Fichorova; Elizabeth N Allred; Jonathan L Hecht; Mahmoud A Ismail; Huaiping Yuan; Alan Leviton Journal: Am J Obstet Gynecol Date: 2011-02-24 Impact factor: 8.661
Authors: Alan Leviton; Karl Kuban; T Michael O'Shea; Nigel Paneth; Raina Fichorova; Elizabeth N Allred; Olaf Dammann Journal: J Pediatr Date: 2011-01-15 Impact factor: 4.406
Authors: Barbara J Stoll; Nellie Hansen; Avroy A Fanaroff; Linda L Wright; Waldemar A Carlo; Richard A Ehrenkranz; James A Lemons; Edward F Donovan; Ann R Stark; Jon E Tyson; William Oh; Charles R Bauer; Sheldon B Korones; Seetha Shankaran; Abbot R Laptook; David K Stevenson; Lu-Ann Papile; W Kenneth Poole Journal: Pediatrics Date: 2002-08 Impact factor: 7.124
Authors: Alan Leviton; Robert M Joseph; Raina N Fichorova; Elizabeth N Allred; H Gerry Taylor; T Michael O'Shea; Olaf Dammann Journal: J Neuroimmune Pharmacol Date: 2018-09-06 Impact factor: 4.147
Authors: Maheer Faden; Mari Holm; Elizabeth Allred; Raina Fichorova; Olaf Dammann; Alan Leviton Journal: Cytokine Date: 2016-09-24 Impact factor: 3.861
Authors: T Michael O'Shea; Robert M Joseph; Karl C K Kuban; Elizabeth N Allred; Janice Ware; Taryn Coster; Raina N Fichorova; Olaf Dammann; Alan Leviton Journal: Pediatr Res Date: 2014-04-10 Impact factor: 3.756
Authors: Carl L Bose; Matthew M Laughon; Elizabeth N Allred; T Michael O'Shea; Linda J Van Marter; Richard A Ehrenkranz; Raina N Fichorova; Alan Leviton Journal: Cytokine Date: 2012-11-11 Impact factor: 3.861
Authors: Alan Leviton; Stephen R Hooper; Scott J Hunter; Megan N Scott; Elizabeth N Allred; Robert M Joseph; T Michael O'Shea; Karl Kuban Journal: Pediatr Neurol Date: 2017-12-21 Impact factor: 3.372
Authors: Alan Leviton; Elizabeth N Allred; Raina N Fichorova; Karl C K Kuban; T Michael O'Shea; Olaf Dammann Journal: Acta Paediatr Date: 2015-12-23 Impact factor: 2.299
Authors: Carmen L Soto-Rivera; Raina N Fichorova; Elizabeth N Allred; Linda J Van Marter; Bhavesh Shah; Camilia R Martin; Michael S D Agus; Alan Leviton Journal: Endocrine Date: 2014-07-06 Impact factor: 3.633
Authors: Alan Leviton; Elizabeth N Allred; Raina N Fichorova; Karl C K Kuban; T Michael O'Shea; Olaf Dammann Journal: Early Hum Dev Date: 2015-12-28 Impact factor: 2.079